CRISPR Screen Reveals PACT as a Pro-Viral Factor for Dengue Viral Replication
Viruses · 2024
DOI: 10.3390/v16050725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Shwetha Shivaprasad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, Stanford University SOM, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Dengue Virus, Host-Pathogen Interactions, RNA-Binding Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Jawaharlal Nehru Centre for Advanced Scientific Research, NIH HHS.
Abstract (Originalsprache)
The dengue virus is a single-stranded, positive-sense RNA virus that infects ~400 million people worldwide. Currently, there are no approved antivirals available. CRISPR-based screening methods have greatly accelerated the discovery of host factors that are essential for DENV infection and that can be targeted in host-directed antiviral interventions. In the present study, we performed a focused CRISPR (Clustered Regularly Interspaced Palindromic Repeats) library screen to discover the key host factors that are essential for DENV infection in human Huh7 cells and identified the Protein Activator of Interferon-Induced Protein Kinase (PACT) as a novel pro-viral factor for DENV. PACT is a double-stranded RNA-binding protein generally known to activate antiviral responses in virus-infected cells and block viral replication. However, in our studies, we observed that PACT plays a pro-viral role in DENV infection and specifically promotes viral RNA replication. Knockout of PACT resulted in a significant decrease in DENV RNA and protein abundances in infected cells, which was rescued upon ectopic expression of full-length PACT. An analysis of global gene expression changes indicated that several ER-associated pro-viral genes such as ERN1, DDIT3, HERPUD1, and EIF2AK3 are not upregulated in DENV-infected PACT knockout cells as compared to infected wildtype cells. Thus, our study demonstrates a novel role for PACT in promoting DENV replication, possibly through modulating the expression of ER-associated pro-viral genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology & Immunology, Stanford University SOM, Stanford, CA 94305, USA.
- Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru 560064, Karnataka, India.
ORCID-Profile: Shwetha Shivaprasad, Pavithra Umashankar, Peter Sarnow
Förderung
- NIAID NIH HHS
- Jawaharlal Nehru Centre for Advanced Scientific Research
- NIH HHS
- Department of Science and Technology
- NIH
- Department of Science and Technology, India
- Jawaharlal Nehru Centre for Advanced Scientific Research, India
Zitieren
APA
Shivaprasad, S., Qiao, W., Weng, K. F., Umashankar, P., Carette, J. E., & Sarnow, P. (2024). CRISPR Screen Reveals PACT as a Pro-Viral Factor for Dengue Viral Replication. Viruses. https://doi.org/10.3390/v16050725
Vancouver
Shivaprasad S, Qiao W, Weng KF, Umashankar P, Carette JE, Sarnow P. CRISPR Screen Reveals PACT as a Pro-Viral Factor for Dengue Viral Replication. Viruses. 2024. doi:10.3390/v16050725
BibTeX
@article{Shivaprasad2024,
author = {Shivaprasad, Shwetha and Qiao, Wenjie and Weng, Kuo-Feng and Umashankar, Pavithra and Carette, Jan E and Sarnow, Peter},
title = {CRISPR Screen Reveals PACT as a Pro-Viral Factor for Dengue Viral Replication},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16050725}
}
EUVIMED